Prohibitions Against Discriminatory Practices Relating to 340B Entities and 340B Drugs
S Died in Banking and Insurance
Email me when SB 1638 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track SB 1638. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill makes it illegal for drug makers, health insurers, pharmacy benefit managers and similar payors to block, limit, or treat 340B entities differently when acquiring or reimbursing 340B drugs. Violations are treated as deceptive and unfair trade practices under Florida law. It aims to protect low‑cost drug programs that serve vulnerable patients.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about SB 1638
3 free questions a day, no accountHistory
- Died in Banking and Insurance
- Introduced
- Referred to Banking and Insurance; Health Policy; Rules
- Filed
Sponsors
- Shev Jones (D) · sponsor
- Jones
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when SB 1638 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SB 1638 freeOr ask your AI assistant about SB 1638 directly:
Add to Claude, ChatGPT or Cursor